Cancer screening, surrogates of survival, and the soma
Abstract
Screening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit.
Journal details
Journal Cancer Cell
Volume 38
Issue number 4
Pages 433-437
Available online
Publication date
Full text links
Publisher website (DOI) 10.1016/j.ccell.2020.09.003
Europe PubMed Central 32946774
Pubmed 32946774
Keywords
Related topics
Type of publication